Overregulating the chemistry industry jeopardizes innovation, jobs, and economic growth. Learn more.

TSCA New Chemicals Review Tracking

Last Updated on July 20, 2024

CONTACT US
Telly Lovelace
CONTACT US

New Chemicals Analysis

Section 5 of the 2016 TSCA amendments require EPA to determine if a new chemical substance poses an unreasonable risk before the chemical can be manufactured in or imported to the United States.  The statute requires EPA to make this determination within 90 days and allows EPA to extend the review period up to an additional 90 days. 

Of the 413 new chemicals under TSCA review, 48 have been under review for less than 90 days.

90-Day Backlog

The remaining 365 (88%) new chemicals have been under EPA review for more than 90 days. a 7% increase since May 17 — resulting in a backlog of advanced chemistries ensnared in the EPA’s review pipeline.

365-Day Backlog

While 243 (59%) of PMN cases are under review for greater than or equal to 365 days, 67% of the new chemicals backlog remained under review for greater than or equal to 365 days. Since May 17, the 365-day backlog declined 15%

Delays in TSCA New Chemical Reviews and U.S. Manufacturing 

EPA's inability to meet the mandated 90-day deadline for conducting new chemical reviews has led to a significant backlog in the TSCA New Chemicals Program. This persistent backlog poses a serious threat to American innovation, manufacturing, and global competitiveness.  In a 2022 survey, ACC member companies representing nearly one-fifth of U.S. chemical industry sales reported systemic delays, disregarded company-submitted data, and inconsistent chemical reviews:

  • 81% reported EPA taking more than 365 days for their new chemical reviews to be completed.
  • 70% of respondents reported that they have decided to introduce new chemicals outside of the U.S. due to uncertainties and challenges with the EPA’s New Chemicals Program. 
  • 70% reported their new chemical reviews being negatively impacted by EPA’s policy change to disregard workplace requirements and protocols to use personal protective equipment (PPE).
  • 66% reported their biggest problem to be EPA delays in new chemical reviews and the resulting inability to start manufacturing in the U.S.

Read ACC’s backgrounder on EPA’s TSCA New Chemicals Program

Understanding ACC’s Tracking of EPA’s Progress in TSCA New Chemical Reviews

ACC developed these visualizations to help interpret and track EPA’s performance of the TSCA New Chemicals Program. The data and information were compiled from the following EPA sources: 1) the New Chemicals case tracker and, 2) the Premanufacture Notices (PMNs) and Significant New Use Notices Table

Click on the links below for more visuals and analysis tracking EPA’s progress in determining Premanufacturing Notices (PMN) and Section 5 Exemptions.


Tracking Progress

* The data is from 2017 to the present and is updated monthly. While the data from the two EPA sources has some discrepancies, the information is indicative of the status of the EPA’s New Chemicals program.